Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 17, 2013

View Archived Issues

Identification of a unique series of small-molecule antiproliferative chromatin adaptor inhibitors

Evaluation of antibody-based delivery of IL-2 for the treatment of blood cancers

A priming dendritic cell-based vaccine confers broad-spectrum antitumor immunity

Results of HIV-CORE002 trial of HIVconsv vaccines reported

Discovery of novel EP4 agonists reported by Cayman Chemical Company, Myometrics

Constellation Pharmaceuticals discovers novel EZH2 inhibitors for cancer

Kadmon planning phase II trials of KD-025 in three indications

Helix BioPharma completes interim review of phase I/II study of L-DOS47 in lung cancer

Synthetic Biologics begins manufacture of SYN-004 for evaluation against C. difficile infections

Radiotherapy/imaging with trimeric GEBP11 peptide assessed in gastric cancer

MED12 expression as a prognostic marker in NSCLC

Johnson & Johnson reviews third quarter 2013

Lytix Biopharma receives clearance to conduct phase I study of LTX-315

FDA approves Novoeight for use in adults and children with hemophilia A

Esteve reports data from phase II study of E-58425 in acute pain

FDA agrees with Omeros' pediatric study plan for OMS-302

Hanmi Pharmaceutical advances new biological drug for diabetes to phase IIb trials

Phase III alirocumab results show efficacy superior to ezetimibe

RedHill's combination therapy achieves 80% remission in pediatric patients with Crohn's disease

Dynavax reveals design of phase III trial of hepatitis B vaccine

FDA committee votes against approval of Vascepa

FDA extends review of AMAG's sNDA to expand indication for Feraheme

Scientists at EnVivo Pharmaceuticals patent novel PDE9A inhibitors

Taiho Pharmaceutical synthesizes new vasopressin receptor antagonists

New JCV neutralizing antibodies discovered at Biogen Idec

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...